Navigation Links
FDA Establishes New Product Codes for Interbody Devices With Integrated Fixation
Date:11/30/2011

CLEVELAND, Nov. 30, 2011 /PRNewswire/ --RSB Spine announced today that it received a revised FDA clearance letter for the InterPlate® System as both an interbody implant with integrated fixation and an anterior screw fixation device.  FDA recently instituted new product codes for stand-alone interbody devices with integrated fixation.   The new code for lumbar interbody devices is OVD, and the new code for cervical interbody devices is OVE.   In addition to these new product codes, the InterPlate retained code KWQ for anterior screw fixation in the spine.

Stand-alone interbody fusion devices were introduced in the U.S. in 2004. They generally consist of an interbody spacer with screw fixation or other mechanisms that engage adjacent vertebrae.  The North American Spine Society (NASS) issued a statement in SpineLine (Coding for Anterior Lumbar Arthrodesis & Instrumentation, November/December, 2007) stating that such devices should be coded as "22558: Arthrodesis, anterior interbody technique..." and "22851: Application of intervertebral biomechanical device…". The guideline further stated that "An additional anterior instrumentation code (22845) is not applicable because there is not a separate construct placed across the vertebral segment."  The American Academy of Professional Coders (AAPC) also adopted the NASS position.

"There has been a great deal of confusion and controversy with stand-alone interbody devices," said Dahari D. Brooks, M.D. of Greensboro Orthopaedics in Greensboro, North Carolina. "The new FDA codes make it easier for surgeons to properly bill and insurers to properly reimburse for these interbody technologies."

"The InterPlate product line is a modular interbody platform and in that regard is different than other stand-alone implants," said John Redmond, CEO of RSB. "The new FDA codes and the retention of our KWQ code help to clarify this difference and provide surgeons with the advantages of a stand-alone implant and the ability to code as a typical anterior plate construct."

RSB Spine is a privately held medical device company focused on developing innovative spinal implants with a focus on modular fusion products. News releases and other information on the company are available on the Internet at: http://www.rsbspine.com.


'/>"/>
SOURCE RSB Spine
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Skyline Diagnostics Establishes Research Collaboration With Janssen
2. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
3. Cellectis bioresearch Establishes The Genome Customization Award (TGCA)
4. Medicare Establishes Reimbursement Coverage for Vermillions OVA1(TM) Test
5. Medicare Administrator Establishes Reimbursement Coding Policy for Agendias Breast Cancer Recurrence Test MammaPrint(R)
6. Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities
7. Schulman Associates IRB Establishes an Institutional Review Board in Canada
8. Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board
9. HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
10. Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
11. Regado Biosciences Establishes Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
Breaking Biology Technology:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)...  Perkotek an innovation leader in attendance control systems is proud to announce the ... employers to make sure the right employees are actually signing in, and to even ... ... ... ...
Breaking Biology News(10 mins):